Frontiers in Cancer Research for the Elderly: Hearings Before the Select Committee on Aging, House of Representatives, Ninety-sixth Congress, First Session, June 19, 20, and 21, 1979
U.S. Government Printing Office, 1979 - Cancer - 536 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
activity addition agents American appear approach associated biological blood bone breast cancer cancer research cancer treatment cause cells centers Chairman Pepper chemotherapy clinical trials combination committee common complete cost cure death DeVita disease doctors drugs early effect effort evaluation fact factors field funds given going hear hope hospital human immune immunotherapy important improved increased infection initial interest interferon involved less leukemia lives lung cancer major malignant material methods million months National Cancer Institute normal occur Oncology patients percent possible prepared present problem production progress prostate question radiation received recent reference reported response risk significant stage statement studies successful surgery Thank therapy tion treated treatment tumor United vincristine women
Page 14 - The moral test of government is how it treats those who are in the •dawn of life, the children, those who are in the twilight of life, the
Page 167 - DEPARTMENT OF DEVELOPMENTAL THERAPEUTICS, UNIVERSITY OF TEXAS SYSTEM CANCER CENTER, MD ANDERSON HOSPITAL AND TUMOR INSTITUTE, HOUSTON, TEX.
Page 360 - I am a professor of Medicine at the University of Texas Cancer Center, MD Anderson Hospital and Tumor Institute, Houston, Texas. I am a board certified internist and oncologist with sub-specialty certification in Hematology. I have been involved for the last eight years in the clinical and laboratory investigation of
Page 360 - antiviral, hormone-like protein that is produced by most human cells. Interferon has been traced back in the evolutionary scale to fish and amphibians. Today, it is believed that interferon is the body's first line of defense against viral infections. Interferon's ability to slow down or stop the growth of cancer cells was discovered in
Page 360 - which is produced by most of the tissue cells of the body. A third type of interferon is called immune interferon. The production of interferon from these cells is a very expensive process. Thus, the amount of interferon available for clinical investigation is extremely limited and expensive. Although chemists are
Page 371 - THERAPEUTICS, UNIVERSITY OF TEXAS SYSTEM CANCER CENTER, MD ANDERSON HOSPITAL AND TUMOR INSTITUTE, HOUSTON, TEX.
Page 491 - It is erroneous to think of cancer as a single disease with a single cause that will be subject to a single form of immunization (as in the case of polio) or a single cure. Cancer comprises many diseases . . . and
Page 453 - Human Leukocyte Interferon in the Treatment of Varicella in Children with Cancer: a Preliminary Controlled Trial ANN M. ARV1N," SANDOR FELDMAN,' AND THOMAS C. MERIGAN 1 Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California,
Page 468 - Kaplan PM, Greenman RL. Gerin JL. et al: DNA polymerase associated with human hepatitis B antigen. J Virol 12:995-1005, 1973 16. Robinson WS, Greenman RL: DNA polymerase in the core of the human hepatitis B virus candidate. J Virol 13:1231-1236, 1974 17. Robinson WS. Clayton DA. Greenman RL: DNA of a human hepatitis B virus candidate. J Virol 14:384-391, 1974